BacterioScan: St. Louis biotech firm raises portion of bridge round

BacterioScan, a St. Louis biotech company that uses laser technology to rapidly test for urinary tract infections, has raised $1.7 million of a planned $4 million bridge round. The money will help bridge the gap between BacterioScan's $6 million Series A round, closed at the end of last year, and its Series B round, which company officials should begin raising at the end of this year. BacterioScan President and CEO Dana Marshall said the money will help wrap the company's development of its...